New Gene Expression Test Helps Guide Atopic Dermatitis Treatment Decisions
Castle Biosciences' AdvanceAD-Tx test identifies patients more likely to respond to JAK inhibitor therapy versus Th2-targeted treatments.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Singular Genomics Launches High-Throughput Spatial Analysis Platform in US
The G4X system can analyze 128 samples per run with 500-plex RNA and 18-plex protein capabilities, targeting translational research and clinical applications.
Equipment & Supply Spotlight
New England Biolabs Releases Magnetic Bead Kit for Cell-Free DNA Extraction
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
News, Know-How & Standards
Disease Detection & Understanding
Guardant Health Offers Free Colorectal Cancer Screening Tests Through Community Grant Program
Guardant Health will provide up to 100 free Shield blood tests per organization to support colorectal cancer screening events and outreach during Colorectal Cancer Awareness Month in March.
